Similar articles

• The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.

  Harry JD, Linden RJ, Snow HM. Harry JD, et al. Br J Pharmacol. 1974 Oct;52(2):275-81. doi: 10.1111/j.1476-5381.1974.tb09710.x. Br J Pharmacol. 1974. PMID: 4155991 Free PMC article.
• Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.

  Baum T, Rowles G, Shropshire AT, Gluckman MI. Baum T, et al. J Pharmacol Exp Ther. 1971 Feb;176(2):339-49. J Pharmacol Exp Ther. 1971. PMID: 4398186 No abstract available.
• The effect of beta-adrenergic blocking drugs on myocardial function: an explanation at the subcellular level.

  Nayler WG. Nayler WG. Postgrad Med J. 1970 Nov:Suppl:90-6. Postgrad Med J. 1970. PMID: 4395466 No abstract available.
• [Review of literature and experimental contribution on KO 592 a drug with beta-adrenolytic activity. II].

  Marmo E, Caputi AP, Saini RK. Marmo E, et al. Clin Ter. 1972 Jul 19;62(2):117-63. Clin Ter. 1972. PMID: 4403714 Review. Italian. No abstract available.
• [Metabolic effects of various palliative drugs for coronary insufficiency].

  Deltour G. Deltour G. Therapie. 1970 Mar-Apr;25(2):293-322. Therapie. 1970. PMID: 4404034 Review. French. No abstract available.